Contents

Current Drug Targets, Volume 10 - Number 10

First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dellAdulto) Multiple Myeloma Working Party Perspective

, 10(10): 906 - 922

Pellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, Luca Baldini, Sara Bringhen, Tommaso Caravita, Francesco Di Raimondo, Fortunato Morabito, Massimo Offidani, Maria Teresa Petrucci, Patrizia Tosi, Francesca Gay, Michele Cavo, Mario Boccadoro and Antonio Palumbo


DOI: 10.2174/138945009789577936




Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

, 10(10): 923 - 936

Antonio Gualberto and Michael Pollak


DOI: 10.2174/138945009789577945




Targeting Sarcomas: Novel Biological Agents and Future Perspectives

, 10(10): 937 - 949

Devalingam Mahalingam, Alain Mita, Kamalesh Sankhala, Ronan Swords, Kevin Kelly, Francis Giles and Monica M. Mita


DOI: 10.2174/138945009789577990




Drug Targeting Through Pilosebaceous Route

, 10(10): 950 - 967

Rashmi Chourasia and Sanjay K. Jain


DOI: 10.2174/138945009789577918




Proteasome Inhibitors in Cancer Therapy

, 10(10): 968 - 981

Ugo Testa


DOI: 10.2174/138945009789577909




Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies

, 10(10): 982 - 1000

Vincenzo Emanuele Chiuri, Nicola Silvestris, Andrea Tinelli and Vito Lorusso


DOI: 10.2174/138945009789578007




Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation

, 10(10): 1001 - 1008

A. Dominguez-Rodriguez, P. Abreu-Gonzalez and J. C. Kaski


DOI: 10.2174/138945009789577963




The Paradox of Caffeine-Zolpidem Interaction: A Network Analysis

, 10(10): 1009 - 1020

Michael Myslobodsky


DOI: 10.2174/138945009789577927




Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model

, 10(10): 1021 - 1027

F. Pastorino, D. Di Paolo, M. Loi, P. Becherini, I. Caffa, A. Zorzoli, D. Marimpietri, R. Carosio, P. Perri, P. G. Montaldo, C. Brignole, G. Pagnan, D. Ribatti, T. M. Allen and M. Ponzoni


DOI: 10.2174/138945009789577954




Down with the Erythropoietin. Long Live the Erythropoietin !

, 10(10): 1028 - 1032

Michele Buemi, Antonio Lacquaniti, Davide Bolignano, Valeria Cernaro, Susanna Campo, Giovanni Grasso, Antoine Buemi, Valentina Donato and Alessio Sturiale


DOI: 10.2174/138945009789577981




Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient

, 10(10): 1033 - 1040

F. Meriggi, B. Di Biasi, C. Abeni and A. Zaniboni


DOI: 10.2174/138945009789577891




Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options

, 10(10): 1041 - 1048

Helen C. Maltezou and Sotirios Tsiodras


DOI: 10.2174/138945009789577972




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science